Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)

Medical Sciences : Open Access Journal
Bernhard W RenzMatthias Ilmer

Abstract

The diagnosis of pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis, in particular, when patients present with unresectable disease. While significant progress has been made in understanding the biology of PDAC, this knowledge has not translated into a clear clinical benefit and current chemotherapeutic strategies only offer a modest improvement in overall survival. Accordingly, novel approaches are desperately needed. One hypothesis that could-at least in part-explain the desolate response of PDAC to chemotherapy is the so-called cancer stem cell (CSC) concept, which attributes specific traits, such as chemoresistance, metastatic potential and a distinct metabolism to a small cellular subpopulation of the whole tumor. At the same time, however, some of these attributes could make CSCs more permissive for novel therapeutic strategies with compounds that are already in clinical use. Most recently, several publications have tried to enlighten the field with the idea of repurposing established drugs for antineoplastic use. As such, recycling drugs could present an intriguing and fast-track method with new therapeutic paradigms in anti-cancer and anti-CSC treatments. Here, we aim to summarize important aspects and n...Continue Reading

References

Nov 2, 2001·Nature·T ReyaI L Weissman
Dec 21, 2006·Cell Research·Feng LiYibin Kang
Feb 7, 2007·Cancer Research·Chenwei LiDiane M Simeone
Nov 26, 2009·Nature Cell Biology·Ulrich WellnerThomas Brabletz
Jan 6, 2010·EMBO Molecular Medicine·Jose Miguel López-Novoa, M Angela Nieto
Apr 27, 2010·Nature Cell Biology·Louis VermeulenJan Paul Medema
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Jul 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Desheng LuDennis A Carson
Sep 29, 2011·Gastroenterology·Chenwei LiDiane M Simeone
Apr 19, 2012·Biochemical and Biophysical Research Communications·Shin HamadaTooru Shimosegawa
May 12, 2012·Nature Reviews. Cancer·Thomas Brabletz
Jun 13, 2012·World Journal of Gastroenterology : WJG·Hou-Min ZhouMin-Hua Zheng
Oct 2, 2013·The Lancet Oncology·Werner HartwigMarkus W Büchler
Nov 10, 2013·PloS One·Enza LonardoChristopher Heeschen
Feb 22, 2014·Cell Death & Disease·R Blum, Y Kloog
Mar 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jiujie CuiKeping Xie
May 3, 2014·Molecular Cancer Therapeutics·Anamaria BalicChristopher Heeschen
May 21, 2014·ELife·William W WheatonNavdeep S Chandel
Sep 30, 2014·Nature Methods·Irene Miranda-LorenzoChristopher Heeschen
Apr 16, 2015·EMBO Molecular Medicine·Simone MeidhofThomas Brabletz
May 23, 2015·International Journal of Oncology·Agnès GarnierMatthias Ilmer
Sep 1, 2015·Oncotarget·Parthasarathy RangarajanAnimesh Dhar

❮ Previous
Next ❯

Citations

Mar 22, 2019·The Cancer Journal·Matthias IlmerBernhard W Renz
Sep 17, 2020·Journal of Cellular and Molecular Medicine·Md Abdul Alim Al-Bari
Apr 4, 2021·Biomedicines·Laura De LellisSerena Veschi

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

The Cancer Journal
Christoph Benedikt Westphalen, Kenneth P Olive
Der Pathologe
L HäberleIrene Esposito
Current Pathobiology Reports
Maria Giovanna FrancipaneEric Lagasse
© 2022 Meta ULC. All rights reserved